Modifying the release of a drug product’s active pharmaceutical ingredient (API) is one of the most significant areas of innovation in small-molecule oral solid dosage (OSD) forms. However, formulating drug products to modify or sustain the point of release can be a sizable challenge to drug developers, motivating many to turn to experienced contract development … Continued